Inventor · disambiguated record
Oliver Keil
Also filed as: KEIL OLIVER
15 granted patents·14 pending applications·81 citations·filing 1997–2024
92Inventor score
Files withSILENCE THERAPEUTICS GMBH6SILENCE THERAPEUTICS AG5PANTHERNA THERAPEUTICS GMBH3ASCENDIS PHARMA AS2HERSEL ULRICH2
Top patents by PatentIndex Score
29 records- 0193US8017804B2Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS AG·Filed 2005·Granted Sep 13, 2011·27 cites·7 claims
- 0290US8357722B2Lipids, lipid complexes and use thereofSilence Therpeutics AG·Filed 2011·Granted Jan 22, 2013·8 cites·17 claims
- 0388US9486538B2Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS GMBH·Filed 2015·Granted Nov 8, 2016·3 cites·14 claims
- 0485US10980860B2Diagnosis, prevention and treatment of diseases of the jointASCENDIS PHARMA AS·Filed 2013·Granted Apr 20, 2021·11 cites·15 claims
- 0583US8735453B2Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS AG·Filed 2013·Granted May 27, 2014·2 cites·13 claims
- 0681US8852472B2Coated lipid complexes and their useKEIL OLIVER·Filed 2005·Granted Oct 7, 2014·9 cites·48 claims
- 0780US9125820B2Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS AG·Filed 2014·Granted Sep 8, 2015·1 cites·6 claims
- 0879US9872864B2Sustained release composition of prostacyclinSPROGØE KENNETT·Filed 2012·Granted Jan 23, 2018·6 cites·13 claims
- 0977US10729778B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2017·Granted Aug 4, 2020·1 cites·24 claims
- 1075US9561287B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2012·Granted Feb 7, 2017·3 cites·28 claims
- 1173US9913912B2Carrier-linked prostanoid prodrugsASCENDIS PHARMA AS·Filed 2013·Granted Mar 13, 2018·2 cites·21 claims
- 1273US8232256B2Means for inhibiting the expression of protein kinase 3KAUFMANN JORG·Filed 2007·Granted Jul 31, 2012·4 cites·53 claims
- 1364US2017036990A1Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS GMBH·Filed 2016·Application pending·0 cites
- 1461US2024408014A1Preparation for use in a method for the treatment and/or prevention of a diseasePANTHERNA THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 1556US2023295651A1Recombinant nucleic acid construct and use thereofPANTHERNA THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1656US2011294871A1Lipids, lipid complexes and use thereofKEIL OLIVER·Filed 2011·Application pending·0 cites
- 1755US9387262B2Coated lipid complexes and their useSILENCE THERAPEUTICS GMBH·Filed 2014·Granted Jul 12, 2016·0 cites·15 claims
- 1854US2023263819A1Lipid Composition and Use Thereof for Delivery of a Therapeutically Active Agent to EndotheliumPANTHERNA THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1952US2009074852A1Lipoplex formulations for specific delivery to vascular endotheliumSILENCE THERAPEUTICS AG·Filed 2007·Application pending·0 cites
- 2050US2016303047A1Means for lung specific deliverySILENCE THERAPEUTICS GMBH·Filed 2014·Application pending·0 cites
- 2146US2019038557A1Means for lung specific deliverySILENCE THERAPEUTICS GMBH·Filed 2018·Application pending·0 cites
- 2246US2017296469A1Lipoplex formulations for specific delivery to vascular endotheliumSILENCE THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
- 2344US2009252783A1Means for inhibiting the expression of cd31SILENCE THERAPEUTICS AG·Filed 2007·Application pending·0 cites
- 2443US6489495B2Cationic amphiphiles for liposomal gene transferMAX DELBRUECK CENTRUM·Filed 2001·Granted Dec 3, 2002·0 cites·1 claims
- 2543US2017152288A1LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHYNOVALIX DEUTSCHLAND GMBH·Filed 2017·Application pending·0 cites
- 2643US2013131321A1LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHYBITTERMANN HOLGER·Filed 2011·Application pending·0 cites
- 2742US2003109699A1Amphiphilic quinolylpolyamines as transfer agents for biologically active macromoleculesFiled 2000·Application pending·0 cites
- 2842US2005048108A1Sulphur-containing amphiphilic agents for the transfer of biologically active molecules into cellsG O T THERAPEUTICS GMBH·Filed 2001·Application pending·0 cites
- 2940US6268516B1Cationic amphiphilic lipids for liposomal gene transferMAX DELBRUECK CENTRUM·Filed 1997·Granted Jul 31, 2001·4 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Oliver Keil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →